Because of the risks for sedation, dissociation, respiratory depression, and abuse and misuse, SPRAVATO ® is only available through a restricted program called the SPRAVATO ® Risk …
SPRAVATO® (esketamine) CIII nasal spray is a derivative of ketamine. SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat …
Learn about SPRAVATO® (esketamine) CIII nasal spray, a prescription medicine for two indications. See full Prescribing & Safety Info, including BOXED WARNINGS.
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with …
SPRAVATO ® is a prescription medicine, used along with an antidepressant, taken by mouth to treat: Adults with treatment-resistant depression (TRD) Depressive symptoms in adults with …
SPRAVATO® is a non-competitive N-methyl D-aspartate (NMDA) receptor antagonist indicated, in conjunction with an oral antidepressant, for the treatment of: • Treatment-resistant …
• are allergic to esketamine, ketamine, or any of the other ingredients in SPRAVATO®. If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking …
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) SPRAVATO® is not for use as a …
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat: • Adults with treatment-resistant depression (TRD) • Depressive symptoms in adults with …